Sandip I. Patel

Filings by Sandip I. Patel span 5 companies, the busiest being Akari Therapeutics PLC, AtlasClear Holdings, Inc. and Peak Bio, Inc. Between 5 February 2021 and 14 October 2026, the trades on record add up to 19 filings.

Market trades split into 3 purchases (€23k) and 1 sale (€3,242). Taken together, the purchases exceed the sales by €19k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 5 share grants and 2 option exercises. 2026 to date brings 2 purchases and no sales.

Half of the purchases are above €8,677 and half below.

The record was last updated on 16 October 2026 with a share grant (€82k) in Akari Therapeutics PLC. The last insider purchase was made public on 28 September 2026, 25 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.